SME News » Pharmaceutical Industry News » Company News
MUMBAI: The board of Sun Pharma is slated to meet during the later part of this week to consider internal restructuring of the business.
The board will be declaring the financial results of the company for the first quarter ended June 30, 2012.
Moreover, it would also consider the announcement of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012.